• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌细胞特异性过表达 HDAC4 促进心肌缺血/再灌注损伤。

Myocyte-specific overexpressing HDAC4 promotes myocardial ischemia/reperfusion injury.

机构信息

Department of Emergency Medicine, Department of Medicine, Rhode Island Hospital, Brown University, Providence, RI, USA.

Department of Surgery, Boston University Medical School, Roger Williams Medical Center, 50 Maude Street, Providence, RI, 02908, USA.

出版信息

Mol Med. 2018 Jul 17;24(1):37. doi: 10.1186/s10020-018-0037-2.

DOI:10.1186/s10020-018-0037-2
PMID:30134825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6050730/
Abstract

BACKGROUND

Histone deacetylases (HDACs) play a critical role in modulating myocardial protection and cardiomyocyte survivals. However, Specific HDAC isoforms in mediating myocardial ischemia/reperfusion injury remain currently unknown. We used cardiomyocyte-specific overexpression of active HDAC4 to determine the functional role of activated HDAC4 in regulating myocardial ischemia and reperfusion in isovolumetric perfused hearts.

METHODS

In this study, we created myocyte-specific active HDAC4 transgenic mice to examine the functional role of active HDAC4 in mediating myocardial I/R injury. Ventricular function was determined in the isovolumetric heart, and infarct size was determined using tetrazolium chloride staining.

RESULTS

Myocyte-specific overexpressing activated HDAC4 in mice promoted myocardial I/R injury, as indicated by the increases in infarct size and reduction of ventricular functional recovery following I/R injury. Notably, active HDAC4 overexpression led to an increase in LC-3 and active caspase 3 and decrease in SOD-1 in myocardium. Delivery of chemical HDAC inhibitor attenuated the detrimental effects of active HDAC4 on I/R injury, revealing the pivotal role of active HDAC4 in response to myocardial I/R injury.

CONCLUSIONS

Taken together, these findings are the first to define that activated HDAC4 as a crucial regulator for myocardial ischemia and reperfusion injury.

摘要

背景

组蛋白去乙酰化酶(HDACs)在调节心肌保护和心肌细胞存活方面起着至关重要的作用。然而,目前尚不清楚介导心肌缺血/再灌注损伤的特定 HDAC 同工酶。我们使用心肌细胞特异性过表达活性 HDAC4 来确定激活的 HDAC4 在调节等容灌流心脏中的心肌缺血和再灌注中的功能作用。

方法

在这项研究中,我们创建了心肌细胞特异性过表达活性 HDAC4 的转基因小鼠,以研究活性 HDAC4 在介导心肌 I/R 损伤中的功能作用。在等容心脏中测定心室功能,并使用氯化四唑染色测定梗死面积。

结果

心肌细胞特异性过表达激活的 HDAC4 可促进心肌 I/R 损伤,表现为 I/R 损伤后梗死面积增加和心室功能恢复减少。值得注意的是,活性 HDAC4 过表达导致心肌中 LC-3 和活性 caspase 3 增加,SOD-1 减少。化学 HDAC 抑制剂的传递减轻了活性 HDAC4 对 I/R 损伤的有害影响,揭示了活性 HDAC4 在应对心肌 I/R 损伤中的关键作用。

结论

综上所述,这些发现首次定义了激活的 HDAC4 是心肌缺血和再灌注损伤的关键调节因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/6050730/73914f2551bf/10020_2018_37_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/6050730/5a47758a79f0/10020_2018_37_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/6050730/2242fbab2bee/10020_2018_37_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/6050730/92ad949d3f39/10020_2018_37_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/6050730/73914f2551bf/10020_2018_37_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/6050730/5a47758a79f0/10020_2018_37_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/6050730/2242fbab2bee/10020_2018_37_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/6050730/92ad949d3f39/10020_2018_37_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/6050730/73914f2551bf/10020_2018_37_Fig7_HTML.jpg

相似文献

1
Myocyte-specific overexpressing HDAC4 promotes myocardial ischemia/reperfusion injury.肌细胞特异性过表达 HDAC4 促进心肌缺血/再灌注损伤。
Mol Med. 2018 Jul 17;24(1):37. doi: 10.1186/s10020-018-0037-2.
2
Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium.心脏中活性 HDAC4 的转基因过表达可减弱心脏功能,并加重梗死心肌的重构。
J Appl Physiol (1985). 2018 Dec 1;125(6):1968-1978. doi: 10.1152/japplphysiol.00006.2018. Epub 2018 Oct 4.
3
HDAC4 degradation mediates HDAC inhibition-induced protective effects against hypoxia/reoxygenation injury.组蛋白去乙酰化酶4(HDAC4)的降解介导了组蛋白去乙酰化酶抑制所诱导的对缺氧/复氧损伤的保护作用。
J Cell Physiol. 2015 Jun;230(6):1321-31. doi: 10.1002/jcp.24871.
4
Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.鸢尾素在保护心脏免受缺血再灌注损伤方面发挥着关键作用。
J Cell Physiol. 2017 Dec;232(12):3775-3785. doi: 10.1002/jcp.25857. Epub 2017 May 3.
5
Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition.靶向敲除 NF-κB p50 可减弱组蛋白去乙酰化酶抑制的心脏保护作用。
Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H2154-63. doi: 10.1152/ajpheart.01015.2009. Epub 2010 Apr 9.
6
Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury.组蛋白去乙酰化酶的抑制作用引发针对心肌缺血性损伤的药理预处理效应。
Cardiovasc Res. 2007 Dec 1;76(3):473-81. doi: 10.1016/j.cardiores.2007.08.010. Epub 2007 Aug 23.
7
LncRNA TUG1 competitively binds to miR-340 to accelerate myocardial ischemia-reperfusion injury.长链非编码 RNA TUG1 竞争性结合 miR-340 加速心肌缺血再灌注损伤。
FASEB J. 2021 Jan;35(1):e21163. doi: 10.1096/fj.202000827RR. Epub 2020 Nov 8.
8
Specific inhibition of HDAC4 in cardiac progenitor cells enhances myocardial repairs.心脏祖细胞中HDAC4的特异性抑制增强心肌修复。
Am J Physiol Cell Physiol. 2014 Aug 15;307(4):C358-72. doi: 10.1152/ajpcell.00187.2013. Epub 2014 Jun 18.
9
Suppression of Excessive Histone Deacetylases Activity in Diabetic Hearts Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondria Apoptosis Pathway.抑制糖尿病心脏中过度的组蛋白去乙酰化酶活性通过线粒体凋亡途径减轻心肌缺血/再灌注损伤。
J Diabetes Res. 2017;2017:8208065. doi: 10.1155/2017/8208065. Epub 2017 Jan 16.
10
Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.选择性抑制I类而非IIb类组蛋白去乙酰化酶可对心脏起到缺血再灌注保护作用。
J Mol Cell Cardiol. 2014 Jul;72:138-45. doi: 10.1016/j.yjmcc.2014.03.005. Epub 2014 Mar 13.

引用本文的文献

1
Epigenetic Mechanisms in Heart Diseases.心脏病中的表观遗传机制
Rev Cardiovasc Med. 2025 Jul 30;26(7):38696. doi: 10.31083/RCM38696. eCollection 2025 Jul.
2
Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review).组蛋白去乙酰化酶4:心血管疾病的治疗靶点(综述)
Int J Mol Med. 2025 Oct;56(4). doi: 10.3892/ijmm.2025.5599. Epub 2025 Aug 1.
3
Transcriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factors.小鼠和人类心肌细胞恢复的转录特征揭示了表观遗传因子的持续上调。

本文引用的文献

1
Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.鸢尾素在保护心脏免受缺血再灌注损伤方面发挥着关键作用。
J Cell Physiol. 2017 Dec;232(12):3775-3785. doi: 10.1002/jcp.25857. Epub 2017 May 3.
2
Sodium Butyrate Protects -Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic Mice.丁酸钠对II型糖尿病小鼠高脂饮食诱导的心脏功能障碍和代谢紊乱具有保护作用。
J Cell Biochem. 2017 Aug;118(8):2395-2408. doi: 10.1002/jcb.25902. Epub 2017 Apr 25.
3
HDAC4 degradation mediates HDAC inhibition-induced protective effects against hypoxia/reoxygenation injury.
Epigenetics. 2025 Dec;20(1):2506625. doi: 10.1080/15592294.2025.2506625. Epub 2025 Jun 5.
4
SETDB1-Mediated Chromatin Regulation in Intestinal Epithelial Cells During Intestinal Ischemia-Reperfusion Injury.肠缺血再灌注损伤期间肠道上皮细胞中 SETDB1 介导的染色质调控
Acta Histochem Cytochem. 2025 Feb 27;58(1):9-18. doi: 10.1267/ahc.24-00061. Epub 2025 Feb 7.
5
Programmed cardiomyocyte death in myocardial infarction.心肌梗死中的程序性心肌细胞死亡
Apoptosis. 2025 Apr;30(3-4):597-615. doi: 10.1007/s10495-025-02075-3. Epub 2025 Jan 20.
6
Targeting histone deacetylase in cardiac diseases.针对心脏病中的组蛋白去乙酰化酶
Front Physiol. 2024 Jun 24;15:1405569. doi: 10.3389/fphys.2024.1405569. eCollection 2024.
7
Class I and II Histone Deacetylase Inhibitors as Therapeutic Modulators of Dilated Cardiac Tissue-Derived Mesenchymal Stem/Stromal Cells.I 类和 II 类组蛋白去乙酰化酶抑制剂作为扩张型心肌组织来源的间充质干细胞/基质细胞的治疗调节剂。
Int J Mol Sci. 2024 Jun 19;25(12):6758. doi: 10.3390/ijms25126758.
8
Roles of Histone Deacetylase 4 in the Inflammatory and Metabolic Processes.组蛋白去乙酰化酶 4 在炎症和代谢过程中的作用。
Diabetes Metab J. 2024 May;48(3):340-353. doi: 10.4093/dmj.2023.0174. Epub 2024 Mar 22.
9
Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition.亮氨酸补充通过组蛋白去乙酰化酶 4 抑制改善 HFpEF 的舒张功能。
Cells. 2023 Nov 2;12(21):2561. doi: 10.3390/cells12212561.
10
SNHG 12 and hsa-miR-140-5P may play an important role in the ceRNA network related to hypertrophic cardiomyopathy.SNHG 12和hsa-miR-140-5P可能在与肥厚型心肌病相关的ceRNA网络中发挥重要作用。
J Thorac Dis. 2023 Mar 31;15(3):1353-1363. doi: 10.21037/jtd-23-189. Epub 2023 Mar 27.
组蛋白去乙酰化酶4(HDAC4)的降解介导了组蛋白去乙酰化酶抑制所诱导的对缺氧/复氧损伤的保护作用。
J Cell Physiol. 2015 Jun;230(6):1321-31. doi: 10.1002/jcp.24871.
4
Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts.组蛋白去乙酰化酶诱导的心肌修复受梗死心脏中 c-kit 的抑制。
J Biol Chem. 2012 Nov 16;287(47):39338-48. doi: 10.1074/jbc.M112.379115. Epub 2012 Sep 28.
5
Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis.组蛋白去乙酰化酶抑制通过刺激内源性血管生成来保护心肌功能和预防心脏重构。
J Pharmacol Exp Ther. 2012 Apr;341(1):285-93. doi: 10.1124/jpet.111.189910. Epub 2012 Jan 23.
6
Therapeutic potential for HDAC inhibitors in the heart.HDAC 抑制剂在心脏中的治疗潜力。
Annu Rev Pharmacol Toxicol. 2012;52:303-19. doi: 10.1146/annurev-pharmtox-010611-134712. Epub 2011 Sep 26.
7
HDAC inhibition promotes cardiogenesis and the survival of embryonic stem cells through proteasome-dependent pathway.组蛋白去乙酰化酶抑制通过蛋白酶体依赖途径促进心脏生成和胚胎干细胞的存活。
J Cell Biochem. 2011 Nov;112(11):3246-55. doi: 10.1002/jcb.23251.
8
Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy.组蛋白去乙酰化酶(HDAC)抑制剂通过抑制自噬来减轻心肌肥厚。
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4123-8. doi: 10.1073/pnas.1015081108. Epub 2011 Feb 18.
9
Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition.靶向敲除 NF-κB p50 可减弱组蛋白去乙酰化酶抑制的心脏保护作用。
Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H2154-63. doi: 10.1152/ajpheart.01015.2009. Epub 2010 Apr 9.
10
The many roles of histone deacetylases in development and physiology: implications for disease and therapy.组蛋白去乙酰化酶在发育和生理学中的多种作用:对疾病和治疗的影响。
Nat Rev Genet. 2009 Jan;10(1):32-42. doi: 10.1038/nrg2485.